NasdaqCM - Delayed Quote • USD
Nephros, Inc. (NEPH)
At close: April 24 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -0.04 | -0.01 | -0.06 | 0.01 |
| Low Estimate | -0.06 | -0.02 | -0.08 | 0.01 |
| High Estimate | -0.02 | -0.01 | -0.05 | 0.01 |
| Year Ago EPS | -0.03 | -0.04 | -0.15 | -0.06 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | 3.73M | 4.11M | 16.7M | 18.79M |
| Low Estimate | 3.43M | 3.98M | 16.34M | 18.79M |
| High Estimate | 4.04M | 4.24M | 17.06M | 18.79M |
| Year Ago Sales | 3.7M | -- | 14.24M | 16.7M |
| Sales Growth (year/est) | 0.90% | -- | 17.30% | 12.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.02 | -0.05 | -0.06 | -0.02 |
| EPS Actual | -0.03 | -0.04 | -0.02 | -0.06 |
| Difference | -0.01 | 0.01 | 0.04 | -0.04 |
| Surprise % | -50.00% | 20.00% | 66.70% | -200.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.04 | -0.01 | -0.06 | 0.01 |
| 7 Days Ago | -0.04 | -0.01 | -0.06 | 0.01 |
| 30 Days Ago | -0.04 | -0.01 | -0.06 | 0.01 |
| 60 Days Ago | -0.03 | -0.01 | -0.04 | 0.04 |
| 90 Days Ago | -0.03 | -0.01 | -0.04 | 0.04 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NEPH | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -33.30% | -- | -- | 2.60% |
| Next Qtr. | 75.00% | -- | -- | 13.40% |
| Current Year | 60.00% | -- | -- | 5.20% |
| Next Year | 116.70% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.11% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Upgrade | Benchmark: Hold to Speculative Buy | 3/8/2024 |
| Initiated | B. Riley Securities: Buy | 1/26/2021 |
| Initiated | Benchmark: Speculative Buy | 10/24/2019 |
| Initiated | Maxim Group: Buy | 10/4/2019 |
Related Tickers
NXGL NEXGEL, Inc.
2.2850
-1.93%
KRMD KORU Medical Systems, Inc.
2.1900
-0.45%
PDEX Pro-Dex, Inc.
18.46
-0.32%
MHUA Meihua International Medical Technologies Co., Ltd.
0.6610
+1.69%
INFU InfuSystem Holdings, Inc.
7.61
-3.30%
HBIO Harvard Bioscience, Inc.
3.5600
-3.52%
ANGO AngioDynamics, Inc.
5.78
-1.53%
MBOT Microbot Medical Inc.
0.8632
-3.12%
EMBC Embecta Corp.
10.40
-4.50%
GCTK GlucoTrack, Inc.
0.4600
-3.97%